|Year : 2018 | Volume
| Issue : 2 | Page : 51-58
Does opium have benefit for coronary artery disease? A systematic review
Tolou Hasandokht1, Arsalan Salari2, Soheil Soltani Pour3, Heidar Dadkhah Tirani2, Bijan Shad2, Elyas Rajabi2
1 Cardiovascular Disease Research Center, Department of Cardiology, Heshmat Hospital, School of Medicine; Department of Community Medicine, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
2 Cardiovascular Disease Research Center, Department of Cardiology, Heshmat Hospital, School of Medicine, Guilan University of Medical Science, Rasht, Iran
3 Department of Community Medicine, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
|Date of Web Publication||22-May-2018|
Dr. Bijan Shad
Department of Cardiology, Guilan Cardiovascular Disease Research Center, Heshmat Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht
Source of Support: None, Conflict of Interest: None
Opium is a plant with euphoria effect. People from some parts of the world traditionally use opium for cardioprotective effects. We did a systematic review to assess the effect of opium on coronary artery disease (CAD). A systematic database search was conducted in PubMed, Web of Science, Google Scholar, Cochrane library, Scopus, and SID from their onset up to June 2016. The quality of the studies was assessed with a standardized scoring system. Articles assessing the effect of opium consumption as orally or smoked were included in this review. Outcome was defined as age on CAD disease, risk of CAD, and morbidity from CAD. Poor methodological studies, animal studies, and studies on cardiovascular risk factors or serum markers were excluded from the review. Three case–control, three cohort, and eight cross-sectional studies were included in this systematic review. The age at the occurrence of myocardial infarction, coronary bypass surgery, and percutaneous intervention in opium users was signifi cantly lower than that of nonusers. Odds ratio of opium consumption for CAD ranged from 1.3 to 3.8 in different studies. Hazard ratio of opium consumption for ischemic heart disease was 1.90 (1.57–2.29) with modification by sex, ethnicity, education level, marital status, residential place, and cigarette smoking. We concluded, in spite of the traditional belief, that the current evidence did not support the protective effect of opium on CAD. Future well-designed studies concerning probable confounders in Iran and other similar parts of world are required.
Keywords: Coronary artery disease, mortality, opium, smoking
|How to cite this article:|
Hasandokht T, Salari A, Pour SS, Tirani HD, Shad B, Rajabi E. Does opium have benefit for coronary artery disease? A systematic review. Res Cardiovasc Med 2018;7:51-8
|How to cite this URL:|
Hasandokht T, Salari A, Pour SS, Tirani HD, Shad B, Rajabi E. Does opium have benefit for coronary artery disease? A systematic review. Res Cardiovasc Med [serial online] 2018 [cited 2021 Mar 5];7:51-8. Available from: https://www.rcvmonline.com/text.asp?2018/7/2/51/232972
| Introduction|| |
Papaver somniferum is a kind of plant which has euphoria effect called opium. Opium is used for medical or recreational purposes in many parts of the word including the Middle East region and in many Asian countries., Tragic reports in 2014 indicated that >20 million people used opium in different forms such as inhalation (vapor, sikh– sang) or oral. Near to 19% of patients with a history of myocardial infarction reported opium consumption. Previous studies suggested several health effects of opium such as analgesic, hypnagogic, anticough, and antidiarrheal effects. Studies showed that patients with chronic disease such as diabetes, hypertension, and ischemic heart disease more use opium than the general population due to traditional medicinal effect of opium on cardiovascular risk factors. It is worth mentioning that, such belief was common among some health-care workers, especially older physicians. Finding this answer can help physicians to give a correct consultation to patients. Many studies were conducted about the relationship between opium consumption and coronary artery disease (CAD). Till now, to our knowledge, no systematic review of these studies has been published. However, in 2016, a perspective article mentioned about the hazardous effects of opium consumption on cardiovascular risk factors. The purpose of this systematic review is to assess the effect of opium consumption on CAD.
| Methods|| |
We searched the following electronic database including PubMed, Web of Science, Google Scholar, Cochrane library, Scopus, and SID in English and Persian languages from their onset up to June 2016 for studies reporting the relationship between opium use and CAD. We defined PICO frame of our review as P: Opium user, C: Nonopium user, O: CAD risk, age on cardiac event. Two independent authors (TH and AS) searched database with the terms (“opium” [tiab] OR “Papaver” [tiab]) AND (“cardiovascular disease” [tiab] OR “Coronary Artery Disease” [tiab] OR “myocardial infarction” [tiab] OR “coronary artery bypass surgery” [tiab] OR “percutaneous coronary intervention” [tiab]). Studies about synthetic opioids such as morphine and fentanyl did not enter into our review. All reference lists of relevant articles were reviewed to identify further reports that could be included in the systematic review. In addition, relevant congress and dissertation research projects registry were searched for identifying unpublished literature such as Proquest and Iranian Registry of Clinical Trials.
After excluding the repeated studies, an initial screen of titles and abstracts was independently conducted by two reviewers (BSH and ER) based on inclusion criteria. A high degree of agreement in the selected literature was reported (kappa coefficient: 0.82). Then, the full articles of the remaining studies were reviewed for further evaluation. This review included observational studies determining the relationship between opium consumption and incidence, disease severity, re-admission, re-vascularization, and mortality from CAD. We included studies reporting opium consumption as orally or smoking. Outcome was defined as age on CAD disease, risk of CAD, severity of CAD and mortality from CAD. We excluded article if it falls under the following criteria: (1) reporting the effect of passive opium, (2) poor methodological quality score, (3) reporting opium effect of cardiovascular risk factors such as hypertension, diabetes, hyperlipidemia, and serum marker, and (4) studying the effect of opium on animals. Quality assessment of selected studies was conducted by two independent (TH and AS) reviewers by the scoring guideline which is used in previous studies [Table 1]., Every question of scoring system was defined as positive (1), negative (0), or unclear (?), with a highest potential grade of 100%. If there is any disagreement, a third reviewer (SS) made a final decision. A score higher than mean (50%) was defined as of high quality. Details of quality score related to each included study are summarized in [Table 2].
Two independent authors (TH and BSh) extracted data using predetermined forms. Data extraction table included first author name, publication year, study location, study design, sample size, frequency of opium consumption, as well as the relationship/association between opium and cardiovascular disease and variables for which the results were controlled by statistical adjustments [Table 3].
| Results|| |
The search to find relative papers located 412 possible references (including duplication between databases). After title screening, we excluded several studies which investigated the opium epidemiology, association between opium and cancer, arrhythmia, or other nonrelevant issues. Furthermore, after abstract screening, some studies were nonrelevant and excluded as follows: 11 studies due to assessing the relation between opium and cardiovascular risk factors such as hypertension, diabetes, and hyperlipidemia,,,,,,,,,,, two animal studies,, five narrative review articles,,,,, one qualitative study, two studies on serum marker,, and nine on poor methodological quality studies [Figure 1].,,,,,,,,
|Figure 1: PRISMA flow diagram of various stages of selecting articles for present systematic review|
Click here to view
In total, we included 14 studies in this systematic review [Table 2]. Of these, one study was case–control, 11 were cross-sectional, and two were cohort studies. One included study related to the US population and other reviewed studies were conducted in Iran. The total number of patients in reviewed studies was 59,020, and sample size ranged from 91 in a cross-sectional study to 50,045 in a cohort study. The mean age of CAD patients in opium users and nonusers was 53.3 (10.1) and 66.3 (10.4) years, respectively. Several probable confounders, such as age, sex, and cigarette smoking, were adjusted in some studies.
Four studies investigated the relationship between opium and mortality, angiographic findings, functional class, and the need for revascularization in patients with acute myocardial infarction (AMI).,,, Five studies examined the opium prevalence, CAD severity, and mortality in patients who underwent coronary angiography (CAG).,,,, Two studies assessed the prevalence of opium consumption, in-hospital mortality, rehospitalizations, and postoperative complications in coronary artery bypass graft (CABG) surgery patients., One cross-sectional study with 125 patients in two groups assessed the relationship between opium addiction and microvascular angina. One cross-sectional study assessed the severity of coronary disease in two groups of patients with and without opium or opiate consumption history. And, in a large cohort study with median 4.7-year follow-up per participant, the association of opium consumption with risk of mortality from circulatory disease was investigated.
Frequency of opium user
Prevalence of the opium consumption in patients with AMI ranged from 17% in Isfahan, central area of Iran, to 51% in Kerman, south part of Iran, in 2013. Opium user rate in CAG reports was about 50% (15.7%–44%).,,,, Seventeen percent of the Golestan cohort population reported opium usage. Moreover, approximately 20% of the CABG patients were opium users., Furthermore, opioid consumption rate in microvascular coronary dysfunction (MCD) patients was more prevalent than individuals without MCD (23.2% vs. 7.2%, P < 0.001, respectively).
Age at cardiac event
In four cross-sectional studies with totally sample size of 1745, opioid consumption decreased the age at AMI: three ,, significantly and one  nonsignificantly. In one cross-sectional study with follow-up component, the age of 782 CABG patients in opium users was significantly lower than nonusers (48.0 ± 8.3 vs. 54.4 ± 10.2, P = 0.004, respectively). In another study conducted on 600 CABG and cardiac valve surgery patients, the age at the surgery was similar in opium users and nonusers. In a recent study conducted in patients undergoing percutaneous coronary intervention (PCI), the age at PCI in opium user was lower than nonusers. In four studies conducted on CAD patients who underwent CAG, there was no report about age in opium users and nonusers [Table 2].,,,
Risk of coronary artery disease
In three cross-sectional ,, and one case–control  study with 3735 CAD patients, opium use was a significant risk factor for CAD. Odds ratio (OR) of opium consumption for CAD ranged from 1.3 in Sadeghian study  to 3.8 in Masoomi study. Opium consumption was an independent risk factor for CAD in nonsmokers after adjusting for conventional risk factors (OR = 38, 95% confidence interval [CI] = 2.7–53.17). A large cohort study reported the hazard ratio of opium consumption for ischemic heart disease as 1.90 (1.57–2.29) with modification by sex, ethnicity, education level, marital status, residential place, and cigarette smoking. Furthermore, another case–control study reported opium addiction was an important effective factor of MCD (adjusted OR = 3.575, 95% CI = 1.418–9.016, P = 0.006) based on multivariable logistic regression analysis. On the other hand, multiple logistic regression analysis in Marmor's study  indicated a significant protective effect of opium or opiate against moderate or severe CAD (OR = 0.8, 95% CI = 0.23–01.98 and OR = 0.32, 95% CI = 0.10–0.92, respectively).
Complication after cardiac event
In a cross-sectional study, in-hospital mortality after AMI was 18.6% in those patients with a history of opium consumption versus 6.2% in those without (P = 0.02). However, in three studies conducted in AMI patients, in-hospital mortality was similar with regard to opium consumption.,, Also, in-hospital mortality after CABG in two studies was not different between opium users and nonusers.,
Re-admission frequency, revascularization rate, Intensive Care Unit (ICU) re-admission, postoperative complications including respiratory, neurological, infective, and renal complications, and ICU time and hospital stay , were not lower in opium users compared to nonusers.
Among 782 CABG patients in Safaii et al's. study, opium was an effective factor (P < 0.0001) of readmission due to cardiac event. The study by Sharafi et al. found that opium was not a significant factor on the incidence of the major adverse cardiac event (11 [3.1%] vs. 53 [4.4%]; P = 0.286), in patients undergoing PCI. There were no difference in angiographic findings , and ejection fraction ,, between opium users and nonusers in three of the twelve included studies.
| Discussion|| |
The present systematic review suggests that opium usage cannot delay the age of onset of CAD and decrease the risk of CAD. As well as, in-hospital mortality in opium users was not lower than nonusers. The results of most included studies were adjusted for some effective variables such as age, smoking, and diabetes on CAD. Almost all studies were conducted in Iran with approximately 8% opium users., Valuable data from large Golestan prospective cohort study showed the increased risk of death from circulatory disease associated with opium consumption. According to Ghazavi's study, serum inflammatory markers such as high-sensitivity C-reactive protein (CRP) and some complementary factors and nitric oxide in opium smokers were greater than nonusers. Hence, opium could have harmful effect on the cardiovascular system. However, the results of a cadaver study showed that the long-term exposure to opium or opiate is associated with decreased severity of CAD. The finding of Marmor's study was related to both opium and opiate consumption, whereas, in other reviewed article, only opium usage effect on cardiovascular disease was studied. It is worth nothing that valuable evidence indicated that the second cause of death in opium user was CAD after accident. According to a study on 5900 individuals, using opium could not reduce the odds of diabetes, hypertension, and hypercholesterolemia. Although blood pressure decreases shortly after opium consumption due to vasodilatation, this is an acute reaction. Furthermore, a few hours before the time of next dose of opium consumption, the blood pressure and heart rate elevate. According to Asgary et al's. study, some risk factors for premature atherosclerosis such as HbA1c, high-density lipoprotein-cholesterol, Lpa, apo-B, factor VII, fibrinogen, apo-A, and CRP in opium users were higher than that in nonusers.
Our findings are parallel with that of a recent review which suggested that several types of cancers such as esophagus, stomach, larynx, lung, and urinary bladder was associated with opium usage. In addition to the adverse cardiac effect of opium, Shirani et al., suggested opium as a risk factor for carotid stenosis. Moreover, Masoudkabir et al., in a prospective article reported that opium not only has no cardioprotective effects, but it might have adverse effect.
Some issues must be considered: (1) Traditionally, most opium users smoked tobacco. Hence, the cigarette smoking should be considered as a confounding factor. The results of some included studies in this review were adjusted for smoking, but opium remain risk factor for CAD, (2) There are different ways of opium consumption like inhalation (vapor, sikh– sang), oral, and intravenous with various absorption and blood level of its main sub extract, i.e., morphine. Hence, different cardiovascular effects might be expected. However, in large Golestan cohort study, this adverse cardiac effect of opium was present for various forms of opium and for various methods of consumption, (3) In spite of pure opiates such as heroin, opium is a combination of various materials that may produce different effects. People believe opium (Taryak) in past years was more effective and pure than these days. Therefore, we cannot investigate the health related of opium itself, (4) There are difference in amount of opium consumption and duration of usage among opium user. Some individuals take orally opium in seed bead size or lentil once or twice a day. These probable confounding factors should be considered in designing of the study, in analyzing or interpretation the results, and (5) majority of studies were conducted in Iran except one study from the US. The high prevalence of opium in Iran allows us conducting epidemiological study. These studies conducted in the different parts of Iran with various races and climate. Although, some of them were poor quality, but the result of favorable studies did not support the cardioprotective effect of opium.
| Conclusion|| |
The results of this systematic review did not support the protective effect of opium use on CAD. Future well-designed studies concerning probable confounders in Iran and other similar parts of world are required.
The authors would like to thank to research chancellor of Guilan University of Medical Sciences
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Kulsudjarit K. Drug problem in Southeast and Southwest Asia. Ann N
Y Acad Sci 2004;1025:446-57.
Karbakhsh M, Salehian Zandi N. Acute opiate overdose in Tehran: The forgotten role of opium. Addict Behav 2007;32:1835-42.
Sadr Bafghi SM, Rafiei M, Bahadorzadeh L, Namayeh SM, Soltani MH, Andishmand MM. Is opium addiction a risk factor for acute myocardial infarction? Acta Medica Iranica 2005;43:218-222.
Heydari M, Hashempur MH, Zargaran A. Medicinal aspects of opium as described in avicenna's canon of medicine. Acta Med Hist Adriat 2013;11:101-12.
Karam GA, Reisi M, Kaseb AA, Khaksari M, Mohammadi A, Mahmoodi M, et al.
Effects of opium addiction on some serum factors in addicts with non-insulin-dependent diabetes mellitus. Addict Biol 2004;9:53-8.
Masoudkabir F, Sarrafzadegan N, Eisenberg MJ. Effects of opium consumption on cardiometabolic diseases. Nat Rev Cardiol 2013;10:733-40.
Urquhart DM, Zheng Y, Cheng AC, Rosenfeld JV, Chan P, Liew S, et al.
Could low grade bacterial infection contribute to low back pain? A systematic review. BMC Med 2015;13:13.
Lievense AM, Bierma-Zeinstra SM, Verhagen AP, van Baar ME, Verhaar JA, Koes BW, et al.
Influence of obesity on the development of osteoarthritis of the hip: A systematic review. Rheumatology (Oxford) 2002;41:1155-62.
Esmaeili Nadimi A, Pour Amiri F, Sheikh Fathollahi M, Hassanshahi G, Ahmadi Z, Sayadi AR, et al.
Opium addiction as an independent risk factor for coronary microvascular dysfunction: A case-control study of 250 consecutive patients with slow-flow angina. Int J Cardiol 2016;219:301-7.
Meysamie A, Sedaghat M, Mahmoodi M, Ghodsi SM, Eftekhar B. Opium use in a rural area of the islamic republic of Iran. East Mediterr Health J 2009;15:425-31.
Sharafi A, Pour Hosseini HR, Jalali A, Salarifar M, Nematipour E, Shojanasab M, et al.
Opium consumption and mid-term outcome of percutaneous coronary intervention in men. J Tehran Heart Cent 2014;9:115-9.
Sadeghian S, Graili P, Salarifar M, Karimi AA, Darvish S, Abbasi SH, et al.
Opium consumption in men and diabetes mellitus in women are the most important risk factors of premature coronary artery disease in Iran. Int J Cardiol 2010;141:116-8.
Masoumi M, Shahesmaeili A, Mirzazadeh A, Tavakoli M, Ali AZ. Opium addiction and severity of coronary artery disease: A case-control study. J Res Med Sci 2010;15:27-32.
Safaii N, Kazemi B. Effect of opium use on short-term outcome in patients undergoing coronary artery bypass surgery. Gen Thorac Cardiovasc Surg 2010;58:62-7.
Masoomi M, Ramezani MA, Karimzadeh H. The relationship of opium addiction with coronary artery disease. Int J Prev Med 2010;1:182-6.
Khademi H, Malekzadeh R, Pourshams A, Jafari E, Salahi R, Semnani S, et al.
Opium use and mortality in golestan cohort study: Prospective cohort study of 50,000 adults in Iran. BMJ 2012;344:e2502.
Marmor M, Penn A, Widmer K, Levin RI, Maslansky R. Coronary artery disease and opioid use. Am J Cardiol 2004;93:1295-7.
Asgary S, Sarrafzadegan N, Naderi GA, Rozbehani R. Effect of opium addiction on new and traditional cardiovascular risk factors: Do duration of addiction and route of administration matter? Lipids Health Dis 2008;7:42.
Azarasa M, Azarfarin R, Changizi A, Alizadehasl A. Substance use among iranian cardiac surgery patients and its effects on short-term outcome. Anesth Analg 2009;109:1553-9.
Ahmadi J, Pridmore S, Alimi A, Cheraghi A, Arad A, Parsaeyan H, et al.
Epidemiology of opium use in the general population. Am J Drug Alcohol Abuse 2007;33:483-91.
Azod L, Rashidi M, Afkhami-Ardekani M, Kiani G, Khoshkam F. Effect of opium addiction on diabetes. Am J Drug Alcohol Abuse 2008;34:383-8.
Mohammadali B, Sepideh N, Mohammadreza Khosoosi N, Mirsaeid R, Afshin K. Opium consumption and lipid and glucose parameters in diabetic patients with acute coronary syndrome: A survey in Northern Iran. Tunis Med 2014;92:497-500.
Seddigheh FS, Hasanzadeh M, Arghami A, Sargolzaee MR. Lipid profi le comparison between opium addicts and non-addicts. J Tehran Univ Heart Center 2008;3:169-72.
Kouros D, Tahereh H, Mohammadreza A, Minoo MZ. Opium and heroin alter biochemical parameters of human's serum. Am J Drug Alcohol Abuse 2010;36:135-9.
Yousefzadeh G, Shokoohi M, Najafipour H, Eslami M, Salehi F. Association between opium use and metabolic syndrome among an urban population in Southern Iran: Results of the Kerman Coronary Artery Disease risk factor study (KERCADRS). ARYA Atheroscler 2015;11:14-20.
Najafipour H, Masoomi M, Shahesmaeili A, Haghdoost AA, Afshari M, Nasri HR, et al.
Effects of opium consumption on coronary artery disease risk factors and oral health: Results of kerman coronary artery disease risk factors study a population-based survey on 5900 subjects aged 15-75 years. Int J Prev Med 2015;6:42.
] [Full text]
Rahimi NM, Marefati H, Najafipour H, Rahnama K, Aghaei I, Moosazadeh M. Prevalence of cardiovascular risk factors in diabetic patients and its relationship with opium consumption. J Guilan Univ Med Sci 2013;88:49-57.
Rahimi N, Gozashti MH, Najafipour H, Shokoohi M, Marefati H. Potential effect of opium consumption on controlling diabetes and some cardiovascular risk factors in diabetic patients. Addict Health 2014;6:1-6.
Sedigheh A, Gh Naderi, Soghraty M, Ahmady P, Shahrezaee JR. A study of plasma lipid peroxidation, lipids and blood sugar level in opium addicts comparewith control group. ARYA J 2005;1:72-4.
Sedigheh A, Nizal S, Ali NG, Reza R. Effect of opium addiction on new and traditional cardiovascular risk factors: Do duration of addiction and route of administration matter? Lipids Health Dis 2008;7:42.
Najafipour H, Joukar S. Combination of opium smoking and hypercholesterolemia augments susceptibility for lethal cardiac arrhythmia and atherogenesis in rabbit. Environ Toxicol Pharmacol 2012;34:154-9.
Joukar S, Najafipour H, Malekpour-Afshar R, Mirzaeipour F, Nasri HR. The effect of passive opium smoking on cardiovascular indices of rabbits with normal and ischemic hearts. Open Cardiovasc Med J 2010;4:1-6.
Masoomi M, Zare J, Nasri H, Mirzazadeh A, Sheikhvatan M. Abrupt opium discontinuation has no significant triggering effect on acute myocardial infarction. J Cardiovasc Med (Hagerstown) 2011;12:234-8.
Pugsley MK. The diverse molecular mechanisms responsible for the actions of opioids on the cardiovascular system. Pharmacol Ther 2002;93:51-75.
Ebrahimi M, Kazemi-Bajestani SM, Ghayour-Mobarhan M, Ferns GA. Coronary artery disease and its risk factors status in Iran: A review. Iran Red Crescent Med J 2011;13:610-23.
Najafi M. Opium and the heart: Common challenges in investigation. J Tehran Univ Heart Center 2010;5:113-5.
Dhalla IA. Opium, opioids, and an increased risk of death. BMJ 2012;344:e2617.
Farahani MA, Ghaffari F, Seyed Fatemi N. Opium addiction in patients with coronary artery disease: A grounded theory study. Med J Islam Repub Iran 2015;29:267.
Saadat H, Ziai SA, Ghanemnia M, Namazi MH, Safi M, Vakili H, et al.
Opium addiction increases interleukin 1 receptor antagonist (IL-1Ra) in the coronary artery disease patients. PLoS One 2012;7:e44939.
Shahouzehi B, Shokoohi M, Najafipour H. The effect of opium addiction on serum adiponectin and leptin levels in male subjects: A case control study from Kerman Coronary Artery Disease Risk Factors Study (KERCADRS). EXCLI J 2013;12:916-23.
Khosoosi-Niaki MR, Mahdizadeh H, Farshidi F, Mehdi M, Salehi OM. Evaluation of the role of opium addiction in acute myocardial infarction as a risk factor. Caspian J Internal Med 2013;4:585.
Rahimi Darabad B, Vatandust J, Pourmousavi Khoshknab MM, Hajahmadi Poorrafsanjani M. Survey of the effect of opioid abuse on the extent of coronary artery diseases. Glob J Health Sci 2014;6:83-91.
Aghadavoudi O, Eizadi-Mood N, Najarzadegan MR. Comparing cardiovascular factors in opium abusers and non-users candidate for coronary artery bypass graft surgery. Adv Biomed Res 2015;4:12.
] [Full text]
Harati H, Shamsi A, Firouzkouhi Moghadam M, Seyed Zadeh FS, Ghazi A. The mortality rate of myocardial infraction patients with and without opium dependen. Int J High Risk Behav Addict 2015;4:e22576.
Hosseini SK, Masoudkabir F, Vasheghani-Farahani A, Alipour-Parsa S, Sheikh Fathollahi M, Rahimi-Foroushani A, et al
. Opium consumption and coronary atherosclerosis in diabetic patients: A propensity score-matched study. Planta Med 2011;77:1870-5.
Kazerani H, Rai AR, Heidary-Moghadam R, Asgari N, Nowroozi M, Rasouli MH. Relationship between using raw opium and opioids with coronary artery stenosis based on coronary an-giography findings. J Biol Today's World 2014;3:71-6.
Rezvani MR, Ghandehari K. Is opium addiction a risk factor for ischemic heart disease and ischemic stroke? J Res Med Sci 2012;17:958-61.
Shirani S, Shakiba M, Soleymanzadeh M, Esfandbod M. Can opium abuse be a risk factor for carotid stenosis in patients who are candidates for coronary artery bypass grafting? Cardiol J 2010;17:254-8.
Sadeghian S, Karimi A, Dowlatshahi S, Ahmadi SH, Davoodi S, Marzban M, et al.
The association of opium dependence and postoperative complications following coronary artery bypass graft surgery: A propensity-matched study. J Opioid Manag 2009;5:365-72.
Davoodi G, Sadeghian S, Akhondzadeh S, Darvish S, Alidoosti M, Amirzadegan A. Comparison of specifications, short term outcome and prognosis of acute myocardial infarction in opium dependent patients and nondependents. The J Tehran University Heart Center 2006;1:48-53.
Dehghani F, Masoomi M, Haghdoost AA. Relation of opium addiction with the severity and extension of myocardial infarction and its related mortality. Addict Health 2013;5:35-42.
Roohafza H, Talaei M, Sadeghi M, Haghani P, Shokouh P, Sarrafzadegan N, et al.
Opium decreases the age at myocardial infarction and sudden cardiac death: A long- and short-term outcome evaluation. Arch Iran Med 2013;16:154-60.
Sadeghian S, Darvish S, Davoodi G, Salarifar M, Mahmoodian M, Fallah N, et al.
The association of opium with coronary artery disease. Eur J Cardiovasc Prev Rehabil 2007;14:715-7.
Kamangar F, Shakeri R, Malekzadeh R, Islami F. Opium use: An emerging risk factor for cancer? Lancet Oncol 2014;15:e69-77.
[Table 1], [Table 2], [Table 3]
|This article has been cited by|
||The effects of opium on the cardiovascular system: a review of side effects, uses, and potential mechanisms
| ||Samaneh Nakhaee,Saeedeh Ghasemi,Kimiya Karimzadeh,Nasim Zamani,Samaneh Alinejad-Mofrad,Omid Mehrpour |
| ||Substance Abuse Treatment, Prevention, and Policy. 2020; 15(1) |
|[Pubmed] | [DOI]|
||Opium use and cardiovascular diseases: a systematic review and meta-analysis
| ||Samaneh Nakhaee,Alireza Amirabadizadeh,Mostafa Qorbani,Roland J. Lamarine,Omid Mehrpour |
| ||Critical Reviews in Toxicology. 2020; : 1 |
|[Pubmed] | [DOI]|
||Effects of Resistance, Endurance, and Concurrent Exercise on Oxidative Stress Markers and the Histological Changes of Intestine After Morphine Withdrawal in Rats
| ||Iraj Salehi,Ebrahim Zarrinkalam?,Fatemeh Mirzaei,Ebrahim Abbasi Oshaghi,Kamal Ranjbar,Sara Soleimani Asl |
| ||Avicenna Journal of Medical Biochemistry. 2018; 6(2): 44 |
|[Pubmed] | [DOI]|